meta_pixel
Tapesearch Logo
Log in
Public Health On Call

687 - Two New RSV Products to Protect Infants

Public Health On Call

The Johns Hopkins Bloomberg School of Public Health

Medicine, News, Health & Fitness

4.6644 Ratings

🗓️ 13 November 2023

⏱️ 16 minutes

🧾️ Download transcript

Summary

RSV—respiratory syncytial virus—is a common infection that causes cold-like symptoms but can become very severe in young children and is the leading cause of hospitalization for babies under 1. Dr. Ruth Karron, director of the Johns Hopkins Vaccine Initiative, talks with Dr. Josh Sharfstein about two new products, a vaccine for pregnant people and an antibody treatment for babies, that could substantially lower the rates of severe infections among children. However, the rollout has been slow and people may still have a hard time getting them for their children as RSV season kicks into gear.

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health,

0:05.9

where we bring evidence, experience, and perspective to make sense of today's leading health challenges.

0:16.3

If you have questions or ideas for us, please send an email to public health question at jh.h.edu.

0:23.8

That's public health question at jh.u.edu for future podcast episodes.

0:31.9

This is Lindsay Smith-Rogers, producer of Public Health On Call.

0:35.6

Today, all about the new products intended to reduce

0:38.7

severe RSV infections in babies and young children by 60% or more. Professor Ruth Karen of the Johns

0:45.8

Hopkins Bloomberg School of Public Health speaks to Dr. Josh Sharfstein about what these products

0:50.8

are and why some people are having trouble finding them for their children.

0:55.1

Let's listen.

0:57.4

Dr. Ruth, Karen, thank you so much for joining me on Public Health On Call to talk about

1:02.4

RSV and new products to protect children from RSV infections.

1:08.6

Let's start with the basics.

1:10.3

What does RSV stand for?

1:12.6

Thank you, Josh. And it's really a pleasure to be here with you. RSV stands for respiratory

1:18.7

sensual virus. This is a virus that can infect people of all ages, but can cause severe disease in infants and young children. It is really the

1:32.7

leading cause of hospitalization for children in the U.S. that are under a year of age. But it also

1:39.8

causes even for children who aren't hospitalized, absence from daycare, parents having to take

1:46.1

time off from work. So it's really quite a problem. We've had some strange epidemics in the last

1:53.6

couple of years because of the COVID pandemic and some of our patterns of behavior. But typically,

2:00.5

RSV is a wintertime virus.

2:02.8

It usually starts right around now in our area in Maryland,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.